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Cognitive behavioural therapy (CBT) is one of the treatments of choice for patients with chronic fatigue
syndrome (CFS). However, the factors that predict recovery are unknown.
The objective of this study was to ascertain the recovery rate among CFS patients receiving CBT in
routine practice and to explore possible predictors of recovery.
Recovery was deﬁned as no longer meeting Oxford or CDC criteria for CFS measured at 6 months
follow-up. A composite score representing full recovery additionally included the perception of
improvement, and normal population levels of fatigue and of physical functioning. Logistic regression
was used to examine predictors of recovery. Predictors included age, gender, cognitive and behavioural
responses to symptoms, work and social adjustment, beliefs about emotions, perfectionism, anxiety and
depression at baseline.
At 6 months follow-up 37.5% of the patients no longer met either the Oxford or the CDC criteria for CFS
while 18.3% were fully recovered. Multivariate analyses showed that worse scores on the work and social
adjustment scale, unhelpful beliefs about emotions, high levels of depression and older age were asso-
ciated with reduced odds for recovery.
Recovery rates in this routine practice were comparable to previous RCTs. There was a wide spectrum
of signiﬁcant predictors for recovery.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Chronic fatigue syndrome (CFS) is a heterogeneous and multi-
factorial condition, characterised by fatigue and disability. Two
commonly used criteria are; the Oxford criteria (Sharpe et al., 1991),
and the US Center for Disease Control (CDC) criteria (Fukuda et al.,
1994). While these two criteria are similar, there is not a complete
overlap in terms of included symptoms. The CDC criteria necessi-
tate the presence of several discrete symptoms. The Oxford criteria
are less “detailed” in this respect but require the presence of both
physical and mental fatigue for 6 months or more.
The aetiology is still much debated with some focused on
ﬁnding a speciﬁc cause (Cairns & Hotopf, 2005). Since CFS does not
have pathognomonic manifestations, the diagnostics of CFS re-
mains a clinical endeavour, and suggests that the condition may be
multi-factorial. Our original cognitive behavioural model of CFSCenter for Sleep Disorders,
21 Bergen, Norway. Tel.: þ47
llipropelli.ﬂorida@gmail.com
r Ltd. This is an open access articlesuggested that an initial trigger such as a virus may contribute to a
vicious cycle in which the individual avoids activity for fear of
making symptoms worse (Butler, Chalder, Ron,&Wessely, 1991). In
an effort to manage symptoms people become hypervigilant and
this so called symptom focussing can exacerbate symptoms
(Chalder, Butler, & Wessely, 1996). Surawy and colleagues subse-
quently added to the model by suggesting that pre-morbid char-
acteristics such as conscientiousness and perfectionism
contributed to individuals becoming vulnerable. In addition, pa-
tients with CFS were more likely to hold the belief that showing
emotions was unacceptable (Surawy, Hackmann, Hawton, &
Sharpe, 1995). Cognitive behavioural therapy (CBT) addresses
these factors but in particular focuses on encouraging patients to
become more consistent in engaging in activity before increasing
activity thereby challenging fearful cognitions such as fear avoid-
ance beliefs and catastrophising whilst simultaneously addressing
symptom focussing. CBT and graded exercise therapy (GET) have
proven to be the most effective treatments for CFS with signiﬁcant
improvements in fatigue and disability (Chambers, Bagnall,
Hempel, & Forbes, 2006; White et al., 2011). However, reductionunder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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entail recovery.
Recovery as an outcome has rarely been investigated in CFS
patients. Recovery involves several conditions such as perception of
improvement, perception of symptom reduction and perception of
improvement of fatigue impact. More objectively, recovery entails
no longer meeting the Oxford and the CDC CFS criteria. To recover
may represent a return to premorbid levels of health andwellbeing.
When previously deﬁning recovery from CFS, studies have used the
normal population statistics as a guide. However, for some CFS
patients recovery as deﬁned by the population mean may entail a
level of good health they did not have before their CFS started.
Likewise, “healthy” individuals could regard themselves as fully
functional and still be under the population mean on health
questionnaires. Some studies have thus set the cut-off for recovery
at 1 standard deviation (SD) from the population mean (Deale,
Husain, Chalder, & Wessely, 2001; Knoop, Bleijenberg, Gielissen,
van der Meer, & White, 2007).
Early studies found that up to a quarter of people with CFS who
receive CBT in the context of a randomized controlled trial (RCT)
make a full recovery (Deale et al., 2001; Knoop, Bleijenberg, et al.,
2007). Although Deale and colleagues found that patients recov-
ered there was a slight downward trajectory from the 1 to 5 year
follow-up (Deale et al., 2001). More recently a large multi-centred
four-arm RCT found that 22% of patients in secondary care recov-
ered after CBT, 22% after GET, 8% after adaptive pacing therapy
(APT) and 7% after specialist medical care (White, Goldsmith,
Johnson, Chalder, & Sharpe, 2013). The odds for recovery after
CBT or GET were 3.36 and 3.38 respectively when compared to APT.
This study conﬁrmed that recovery from CFS was possible.
Outside the conﬁnes of an RCT clinical follow-ups have found
that between 0% and 31% of the CFS patients show full recovery
depending on the setting (Cairns & Hotopf, 2005). In Cairns and
Hotopf (2005) systematic review covering various clinical follow-
ups, they found a median of 5% showing full recovery and 39.5%
showing improvement (Cairns & Hotopf, 2005). However, the
studies used different inclusion criteria. Some were conducted in
primary care whereas others were secondary care studies. Some of
the highest recovery rates were found in primary care settings,
possibly involving lower levels of severity or chronicity than those
treated in secondary care. In addition, the studies involved different
types of treatment many of which were not recorded systematically.
The variation in recovery rates in different studies is likely to be
affected by the inclusion criteria used. Furthermore, the recovery
rate will be inﬂuenced by the operationalization of “full recovery”
and the timing of follow-ups in the different studies.
Predictors of outcome after CBT
Several studies have examined predictors of outcomes after CBT.
A recent study examined heterogeneity in terms of symptom
clusters and their association with fatigue outcome. This study
indicated that characteristics in CFS patients may affect respon-
siveness to CBT (Cella, Chalder, & White, 2011). They found that a
higher frequency of weight ﬂuctuation, physical shaking, pain and
anxiety together with higher levels of symptom focussing were
predictive of a negative outcome. Similarly, symptom focussing and
a passive activity pattern had previously been found to predict less
improvement in a randomised controlled trial of CBT (Prins et al.,
2001).
Psychiatric disorders like depression and anxiety represent the
most common co-morbid disorders among CFS patients, and have
been linked to outcome after CBT (Kempke et al., 2010; Prins,
Bleijenberg, & Rouweler, 2005; Sharpe, Hawton, Seagroatt, &
Pasvol, 1992). An association between maltreatment and CFS(Nater et al., 2009) has been found and this may explain some of the
co-morbid anxiety and depression seen in CFS. Interestingly
though, only those people with CFS and childhood trauma had low
cortisol (Nater et al., 2009). Although low cortisol showed a poor
response to CBT in one study (Roberts et al., 2010) reassuringly the
presence of maltreatment did not affect the outcome of CBT for
people with CFS in another (Heins, Knoop, Lobbestael, &
Bleijenberg, 2011).
A number of other factors have been associated with outcome
after CBT. Patients who believe that their illness is primarily physical
aremore likely tohave apooreroutcomeafter CBT (Butler et al.,1991).
Older age has been associated with a poorer outcome (Quarmby,
Rimes, Deale, Wessely, & Chalder, 2007) as has being in receipt of
disablement insurance beneﬁt (Bentall, Powell, Nye, & Edwards,
2002) or being involved in a legal procedure related to ﬁnancial
beneﬁts (Prins, Bazelmans, Van derWerf, Van deMeer,& Bleijenberg,
2001). Focussing speciﬁcally on recovery, data from two randomized
controlled trials were used to examine the association between pain
and outcome from CBT. Recovered adult patients had fewer pain lo-
cations following treatment but higher pain severity at baseline was
associated with a negative treatment outcome (Knoop, Stulemeijer,
Prins, van der Meer, & Bleijenberg, 2007).
In the present study we aimed to investigate recovery rates in
patients who received CBTat a secondary care CFS treatment unit in
routine clinical practice. We looked at differences in recovery rates
at the 6 month follow-up according to different indicators of re-
covery: i) the CDC and the oxford criteria, ii) levels of fatigue, iii)
physical disability and iv) subjective experience of improvement.
We furthermore aimed to investigate the association between the
different indicators of recovery and the following predictors: age,
gender, duration of CFS, anxiety, depression, perfectionism, symp-
tom/illness acceptance, beliefs about emotions, work and social
adjustment and cognitive and behavioural responses to symptoms.
These variables were chosen as they represented aspects of the
cognitive behavioural model of CFS and also took account of the
previous research ﬁndings. Univariate associations were initially
explored. However, subsequently variables included in the multi-
variable analysis were those that were signiﬁcant at 0.1. We pre-
dicted that the presence of distress in the form of anxiety or
depression, symptom focussing, more avoidance behaviour and
unhelpful perfectionism would be associated with not recovering.
Method
Participants
The participants in this study were CFS patients who were
treated with CBT at the Chronic Fatigue Syndrome Unit at South
London and Maudsley, NHS Trust. Outcomes after CBT are
measured routinely and audit approval was given by the Psycho-
logical Medicine Clinical Academic Group (CAG) at the South Lon-
don and Maudsley Hospital to examine predictors of outcome.
All of the participants were diagnosed with CFS in accordance
with the NICE guidelines (Turnbull et al., 2007) and assigned to CBT
based on a clinical assessment. At pre-treatment assessment, all
participants fulﬁlled the NICE guidelines for the CFS criteria (having
fatigue for the last 4 months), 72.7% met the Oxford criteria and
52.6% of the participants met the CDC criteria. This non-
randomized cohort included 200 CFS patients whose treatment
was initiated before August of 2010.
In this study CBT was based on the illness model of fear avoid-
ance, as described in the PACE protocol (White, Sharpe, Chalder,
DeCesare, & Walwyn, 2007). The model involved these funda-
mental elements: (i) reviewing beliefs about the illness and coping
strategies, (ii) re-establishing a stable baseline of general activities
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daily rest, sleep and activity, (iii) collaboration between therapist
and patient in challenging unhelpful beliefs about symptoms and
activity.
Instruments
At the pre-treatment assessment demographic informationwere
obtained (age and gender), as well as information on the number of
months the CFS had persisted. A checklist was used to ascertain
whether patients fulﬁlled the CDC and the Oxford criteria. Self-
report scales included the: Chalder fatigue questionnaire, short
form-36 physical functioning scale, cognitive behavioural response
questionnaire, work and social adjustment scale, beliefs about
emotions scale, hospital anxiety and depression scale, acceptance
scale, and the Frost multidimensional perfectionism scale. At the 6
month follow-up, patients were asked to report their subjective
experience of improvement on the Global improvement scale (Shega
et al., 2007; Guy, 1976) in addition to the aforementioned scales.
Oxford criteria for CFS
The Oxford inclusion criteria for CFS are deﬁned as: i) fatigue is
the main symptom, ii) fatigue symptoms show a deﬁnite onset i.e.,
the problem is not lifelong, iii) fatigue symptoms are severe,
disabling and affect physical and mental function and iv) fatigue is
present 50% of the time for a minimum of 6 months (Sharpe et al.,
1991). Diagnostic exclusion criteria entail the presence of other
medical conditions that are likely to cause fatigue (e.g., severe
depression, anorexia or bulimia nervosa, neurological disorders).
CDC criteria for CFS
The present study employed participant ratings to assess the
CDC inclusion criteria for CFS. The criteria were deﬁned as: i) severe
chronic fatigue for a minimum six months with no other known
medical conditions explaining the symptoms; and ii) Aminimum of
four of the following symptoms: post-exertional malaise, impaired
memory or concentration, non-refreshing sleep, muscle pain,
multi-joint pain without redness or swelling, tender lymph nodes,
sore throat, headache (Fukuda et al., 1994).
Chalder fatigue questionnaire (CFQ)
The CFQ measures symptoms of physical and mental fatigue
(Chalder et al., 1993). Each of the 11-items have a response range
0e3, from ‘less than usual’ to ‘much more than usual’, with a
maximum summed score of 33. The scale can also be scored using
binary coding, yielding a maximum score of 11. The scale has good
psychometric proprieties (Cella & Chalder, 2010). In this study, the
Cronbach's alpha was 0.92.
The physical functioning subscale of the short form-36 (SF-36)
The level of disability i.e., physical functioning, was measured
with the SF-36 (Jenkinson, Layte, Coulter, & Wright, 1996). The
scores range from 0 (maximum physical limitations) to 100 (ability
to do vigorous activity). A score of 65 or higher denotes being
within 1SD of the UK population mean of 83 or higher (Deale et al.,
2001). In the present study the Cronbach's alpha value was 0.92.
Hospital anxiety and depression scale (HADS)
The HADS (Zigmond & Snaith, 1983) measures symptoms of
anxiety (HADS-A) and depression (HADS-D). Scores for each 14items range from 0 to 3 and the maximum summed scores are 21
for both depression and anxiety subscales. Increased scores indi-
cate higher symptom severity. In the present study the Cronbach's
alpha values were 0.83 and 0.78 for HADS-A and HADS-D
respectively.
Acceptance questionnaire
An adapted version of the Pain Acceptance Questionnaire
(McCracken & Eccleston, 2003) was used to assess the level of fa-
tigue acceptance. Pain was substituted for fatigue. The question-
naire was previously used in a study examining outcomes in a CFS
service (Brooks, Rimes, & Chalder, 2011). The 9-item questionnaire
is scored from 0 to 6 (never true to always true). The ﬁrst item in
this questionnaire reads: “I am getting on with the business of
living no matter what my level of fatigue is”. A high summed score
indicates lack of acceptance of fatigue. In the present study, the
Cronbach's alpha for this scale was 0.80.
Frost multi-dimensional perfectionism scale
The Frost Multi-dimensional Perfectionism Scale assesses facets
of perfectionism using statements rated from 1 to 5 (strongly
disagree to strongly agree) (Frost, Marten, Lahart, & Rosenblate,
1990). For the purpose of this study we used the questions per-
taining to unhelpful aspects of perfectionism such as excessive
concern with mistakes, doubt about the quality of personal ac-
complishments, and worrying about parents' expectations and
evaluations. To provide an example the ﬁrst item dealing with
concerns over mistakes reads: “9. If I fail at work/school, I am a
failure as a person”. These issues are measured with four items
(Cronbach's alpha in brackets): concern over mistakes (0.92),
doubts about actions (0.79), parental expectations (0.89), parental
criticism (0.88).
Beliefs about emotions scale (BES)
The BES is a 12-item scale that measures beliefs about emotional
experience and expression. Items are rated on a Likert-type scale
ranging from 0 to 6. A high summed score indicates less adaptive
beliefs. The ﬁrst item of this scale reads: “1. It is a sign of weakness if
I have miserable thoughts”. The BES has good psychometric prop-
erties (Rimes& Chalder, 2010). The Cronbach's alpha in this present
study was 0.89.
Work and social adjustment scale
The work and social adjustment scale (WSAS) (Mundt, Marks,
Shear, & Greist, 2002) measures impairment in work, home man-
agement, relationships, social and private life. This scale has been
validated for patients with CFS (Cella, Sharpe,& Chalder, 2011). The
5 items are scored on an 8-point scale ranging from ‘very severely
impaired’ to ‘not impaired at all’, with amaximum summed score of
40. The ﬁrst item of this scale reads: “Because of my [problem] my
ability to work is impaired. ‘0’ means ‘not at all impaired’ and ‘8’
means very severely impaired to the point I can't work”. In the
present study the Cronbach's alpha value was 0.84.
Cognitive behavioural response questionnaire (CBRQ)
The CBRQ (Skerrett & Moss-Morris, 2006) measures cognitive
and behavioural responses to symptoms of health problems and
illness. The questionnaire includes the following subscales (with
Cronbach's alpha in brackets) i) symptom focussing (excessive
symptoms focus [0.88]), ii) fear avoidance i.e., I am afraid that I will
Table 1
Differences in prevalence rates for CFS criteria and cut-offs at pre-treatment and 6
month follow-up (signiﬁcance tested with chi square analyses), and prevalence for
patients feeling much/better and total recoverya at 6 month follow-up.
Pre-treatment 6 month Follow-up
% (n) % (n)
Meeting Oxford criteria*** 72.7 (125) 53.1 (60)
Meeting CDC criteria*** 52.6 (91) 37.5 (45)
Meeting either Oxford or CDC criteria*** 83.2 (134) 62.7 (69)
>¼18 CFQ* 83.9 (156) 51.4 (71)
<65 SF-36*** 71.1 (133) 49.3 (66)
<83 SF-36*** 87.7 (164) 67.9 (91)
Feeling much better or very much better 60.8 (79)
Total recovery 0 (0)a 18.3 (19)b
*p < 0.05, ***p < 0.001.
CFQ¼ Chalder fatigue questionnaire, SF-36¼medical outcomes short form physical
functioning subscale.
a Total recovery deﬁned as the combination of not meeting CDC and Oxford
criteria, scoring less than 18 on the CFQ and more than 65 or higher on the SF-36.
b Total recovery deﬁned as the combination of not meeting CDC and Oxford
criteria, scoring less than 18 on the CFQ, more than 65 or higher on the SF-36 and
feeling much better or better.
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i.e., If I push myself too hard I will collapse [0.73], iv) embarrass-
ment avoidance i.e., I am ashamed ofmy symptoms [0.81], v) beliefs
about damage i.e., Symptoms are a sign that I am damaging myself
[0.81], vi) all-or-nothing behaviour (either being intensely active or
resting extensively [0.89]), and vii) avoidance/resting (avoiding
behaviour i.e., resting and inactivity [0.77]). All items are rated on a
ﬁve-point Likert scale ranging from “strongly disagree” to “strongly
agree” or “never” to “all the time”. The scale has previously been
used in patients with CFS (Knudsen, Henderson, Harvey, & Chalder,
2011).
Global improvement scale (GIS)
Patients were asked to rate their improvement on a 0e7 point
scale ranging from very much better to very much worse (Guy,
1976). This self-report question has previously been used when
assessing improvement and recovery in CFS patient's (Deale et al.,
2001). For the purpose of this study the “much better” and “very
much better” responses were combined, making a dichotomized
measure of subjective improvement.
Deﬁning recovery
Both the CDC and Oxford criteria are standards bywhich CFS can
be operationalised. As there is not a complete overlap between
these two criteria, both the CDC and Oxford criteria were chosen as
primary conditions for recovery. Yet, notmeeting the CDC or Oxford
Criteria would not necessarily be indicative of a healthy fully
recovered individual. Thus, in this study we also assessed other
indicators of recovery such as the patients' subjective experience of
actually feeling “much better” or “very much better” measured by
the GIS at the 6 month follow-up assessment.
In addition, the CFQ and the SF-36 physical subscale were
employed to indicate whether participants could be considered to
be within normal levels of fatigue and physical functioning at
follow-up. Previous studies have indicated a CFQ score of below 18
and an SF-36 physical function score of 65 or higher are both within
1 SD of the normal population mean score (Deale et al., 2001;
Jenkinson, Coulter, & Wright, 1993). These values were used as
cut-offs in the present study.
Recovery was deﬁned as no longer meeting either the CDC-
criteria or the Oxford criteria. A total recovery score was deﬁned as
no longer meeting the CDC- criteria and the Oxford criteria, and
feeling much better/very much better and scoring below 18 on the
CFQ and scoring 65 or higher on the SF-36.
Statistical analyses
In the present study SPSS 20 was used for all analyses. We
provide the prevalence of the different indicators of recovery, and a
total recovery composite score at 6 month follow up. Numbers and
percentages are calculated for those who did and did not meet the
criteria pre-treatment. Since not all participants fulﬁlled the CDC or
Oxford criteria, or met the cut-offs for CFQ and SF-36 at pre-
treatment assessment, follow-up ﬁgures were compared with
baseline assessments, for those who at baseline met the corre-
sponding criteria, by means of chi square analyses. We also calcu-
lated means and standard deviations for the predictor variables in
the recovered and non-recovered CFS patients.
We performed univariate and multivariate logistic regression
analyses with previously deﬁned recovery indicators as dependent
variables; i) recovery deﬁned as “no longermeeting the CDC criteria
and no longer meeting the oxford criteria”, ii) “feeling much better
or very much better” (GIS), iii) scoring below 18 on the CFQ, and iv)Scoring 65 or higher on the SF-36. Those not meeting the corre-
sponding criteria or cut-off were excluded from both the univariate
and multivariate analyses. The univariate analyses included pre-
treatment assessment of the following: demographic variables
(age, gender), duration of CFS before entering therapy, CBRQ,
acceptance, WSAS, Frost perfectionism scale, BES, HADS-A and
HADS-D. These variables were chosen as they were theoretically
important and/or had been found previously to predict a poor
outcome. In addition to signiﬁcant predictors, variables showing p-
values of 0.1 or less in an univariate analysis were also included in
the corresponding multivariate analysis. We chose this method as a
result of the sample size which could not accommodate a large
number of predictor variables. Those meeting either CDC or Oxford
criteria at pre-treatment assessment were included in the multi-
variate analyses related to feeling much better or better at the 6
month follow-up. We performed preliminary analyses to exclude
the possibility of collinearity in the logistic regression analyses.
Signiﬁcance was set to p < 0.05.
Missing data
For single missing data cells, we performed missing data sub-
stitution using the participant's mean score for that particular scale
or subscale. This was only done where less than 30% of items in the
scale/questionnaire were missing.
Results
There were in total 140 participants with 6 month follow-up
data to be included in analyses (response rate: 72.2%). Five pa-
tients were excluded from analyses due to severe co-morbidity
(cancer, seizures, bipolar disorder and eating disorder) and one
for receiving alternative treatment which alleviated the fatigue
symptoms. Of the remaining 194 patients, 185 (95.4%) completed
the discharge assessment. If patients had not completed the 6-
month follow-up, but had completed the 1 year follow-up, the 1
year assessment data replaced the missing 6 month assessment
(n ¼ 5). Between 6 and 20 sessions were attended, with a mean of
15.3 sessions (SD ¼ 3.7). Preliminary analyses did not reveal any
signiﬁcant differences between patients completing and those not
completing the 6-month follow-up assessment in terms of Oxford
and CDC criteria (chi-square analyses; p > 0.05). Similarly, there
were no differences in baseline cut-offs in fatigue and physical
impairment, or any of the predictor variables that were explored in
Table 2
Means and standard deviation of predictor scores in recovered and not recovered
patients (no longer meeting either Oxford or CDC criteria for CFS) at 6 month follow
up.
Not recovered Recovered
Mean (SD) Mean (SD)
Age 38.4 (11.9) 37.2 (10.1)
Time with CFS 89.9 (80.2) 68.7 (68.8)
HAD e Depression 8.6 (3.8) 7.0 (3.5)
HAD e Anxiety 10. 7 (4.6) 9.4 (4.8)
Beliefs about emotions 36.0 (13.4) 34.9 (12.9)
Acceptance 35.4 (8.6) 35.9 (8.2)
FMPS e Concerns about mistakes 22.6 (9.3) 20.6 (9.2)
FMPS e Doubts over actions 10.9 (3.7) 10.1 (4.5)
FMPS e Parental expectations 11.7 (5.5) 10.6 (5.0)
FMPS e Parental criticism 8.6 (4.4) 7.9 (4.5)
CBRQ e Damaging beliefs 10.3 (4.5) 10.4 (3.3)
CBRQ e Fear avoidance 14.2 (4.1) 13.1 (4.3)
CBRQ e Catastrophizing 8.1 (3.3) 6.5 (3.4)
CBRQ e Embarrassment 12.6 (5.6) 11.6 (5.5)
CBRQ e Avoidance/resting 13.8 (5.5) 12.2 (4.7)
CBRQ e Symptom focussing 13.7 (5.1) 13.4 (4.7)
CBRQ e All-or-nothing 10.9 (5.1) 8.9 (5.0)
Work and social adjustment scale 25.3 (7.7) 19.4 (9.4)
CFS ¼ Chronic fatigue syndrome, HAD ¼ Hospital anxiety and depression scale,
FMPS ¼ Frost multidimensional perfectionism scale, CBRQ ¼ Cognitive and behav-
ioural response questionnaire.
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patients were 18 years or older (mean age of 38.3, SD ¼ 11.6), and
72% were females.
The pre-treatment and 6-month follow-up assessments for each
discrete outcomemeasure are shown in Table 1. Chi square analyses
revealed signiﬁcant change in prevalence rates for all recovery
measures. While 72.2% met the oxford criteria for CFS at pre-
treatment assessment, 53.1% did so at the 6-month follow-up
(Pearson chi square ¼ 19.5, df ¼ 1, p < 0.001). Likewise, chi-
square revealed a signiﬁcant reduction in prevalence from 52.6%
of the participants meeting the CDC criteria at the pre-treatment
assessment to 37.5% at the 6-month follow-up (Pearson chi
square ¼ 16.8, df ¼ 1, p < 0.001). With regard to the combined
Oxford and CDC criteria, as many as 83.2% met either one of the
criteria at pre-treatment, compared to 62.7% at the 6-month
follow-up (Pearson chi square ¼ 11.4, df ¼ 1, p < 0.001). In other
words, deﬁning recovery as no longer meeting any of the criteria
entailed a recovery rate of 37.3% at the 6-month follow-up.
In terms of fatigue symptoms, 83.9% scored 18 or higher on the
CFQ at the pre-treatment assessment, compared to 51.4% at the 6-
month follow-up (Pearson chi square ¼ 4.9, df ¼ 1, p < 0.05). As
shown in Table 1, at pre-treatment assessment, 71.1% of the patients
were below 1 SD of the normal population SF-36 mean score (i.e.,
below 65). At the 6-month follow up, 49.3% was below this cut-off
(Pearson chi square ¼ 5.5, df ¼ 1, p < 0.001). Using the approxi-
mated population mean, 87.7% of the patients scored below the 83
point cut-off at pre-treatment assessment compared to 67.9% below
the cut-off at follow-up (Pearson chi square¼ 32.9, df¼ 1, p< 0.001).
When combining the CDC and oxford criteria, the GIS score
(much better/very much better) as well as the fatigue cut-off (<18)
and the SF-36 cut-off (>¼65) in one composite total recovery score,
18.3% showed total recovery at the 6-month follow-up. None of the
patients met the criteria set for the total composite recovery score
at pre-treatment.
As shown in Table 2, the means of predictor variables were
somewhat different between those showing recovery at the 6-
month follow-up assessment. The signiﬁcance of these predictors
was tested in the logistic regression analyses which now follow.
Recovery deﬁned as not meeting either CDC or Oxford criteria
Firstly, recovery as deﬁned by no longer meeting the Oxford and
CDC criteria was used as dependent variable in the univariate ana-
lyses. As shown in Table 3, the following variables were associated
with a reduced odds for recovery: disability in terms of work and
social adjustment (WSAS), high levels of “catastrophizing” (CBRQ)
and increased symptoms of depression (HADS-D). These signiﬁcant
predictors were included in the multivariate logistic regression
analysis. Additionally, the CBRQ subscale “All or nothing behaviour”
was included in themultivariate analysis as it had a p-value of below
0.1. None of these signiﬁcant results from the univariate analysis
remained signiﬁcant in the multivariate analysis (see Table 4).
Feeling much better or better as indicator of recovery
The dichotomised GIS score, i.e., those who felt much better/
better and those not experiencing such an improvement, were used
as an indicator of recovery and as a dependent variable. In the
univariate analyses we found an association between fear avoid-
ance (CBRQ), disability in terms of work and social adjustment
(WSAS) and increased symptoms of depression (HADS-D). In
addition to the signiﬁcant predictors, the variables “months with
CFS” and unhelpful beliefs about emotions and expression of
emotions (BES) were also included in the multivariate analysis, due
to a p-value below 0.1 in the univariate analysis.The variables unhealthy beliefs about emotions (BES) and high
levels of depression symptoms (HADS-D) were associated with not
feeling better at the 6-month follow-up in themultivariate analysis.
Scoring 18 or less on the CFQ as indicator of recovery
Reduced odds of recovery as measured by means of the CFQ cut-
off (<18), was signiﬁcantly associated with the following variables
in the univariate analysis: being concerned about mistakes
(perfectionism), high parental expectations (perfectionism),
embarrassment avoidance (CBRQ) and disability in terms of work
and social adjustment (WSAS). Additionally, lack of acceptance,
doubts about actions (perfectionism), avoidance/resting (CBRQ)
and increased symptoms of depression (HADS-D) were included as
predictors in the multivariate analysis (p < 0.1).
In the multivariate analysis, WSAS was the only variable with a
reduced odds of recovery as deﬁned by the CFQ cut-off. The control
variable (CFQ cut-off at pre-treatment), was not signiﬁcantly
related to recovery at 6 month follow-up.
Scoring 65 or higher on the SF-36 physical subscale as indicator of
recovery
Using the SF-36 cut-off (>¼65) as a recovery measure, the
following variables were associated with a reduced odds for re-
covery in the univariate analysis: older age, months with CFS, lack
of acceptance, and increased symptoms of depression (HADS-D).
Furthermore the variables catastrophizing, more avoidance/resting
behaviour (CBRQ), disability in terms of work and social adjustment
(WSAS) and all-or-nothing behaviour (CBRQ) were included in the
multivariate analysis (p < 0.1) in addition to the signiﬁcant pre-
dictor variables.
In the multivariate analysis, the predictor variable older age
remained associated with a reduced odds of recovery deﬁned by SF-
36.
Discussion
In this study we investigated recovery rates and examined
predictors of recovery in patients who received CBT at a secondary
Table 3
Associations between predictor variables at baseline assessment and recovery at 6 month follow-up.
Not meeting CDC and
Oxford criteria
Feeling much better or
better
Scoring <18 on the CFQ Scoring >¼65 on the SF-36
OR 95% C.I. OR 95% C.I. OR 95% C.I. OR 95% C.I.
Gender (1) 0.98 0.42 2.31 0.98 0.93 1.03 0.77 0.37 1.60 0.65 0.31 1.37
Age 0.98 0.94 1.03 0.99 0.99 1.01 0.98 0.93 1.03 0.94** 0.90 0.98
Months with CFS 1.00 0.99 1.01 0.97þ 0.90 1.01 1.00 0.99 1.01 0.98* 0.98 0.99
Acceptance 0.96 0.91 1.02 0.97 0.91 1.03 0.95þ 0.88 1.02 1.02 0.97 1.08
FMPS e Concerns about mistakes 0.94 0.83 1.07 0.93 0.80 1.08 0.91** 0.84 0.98 1.01 0.96 1.06
FMPS e Doubts over actions 0.93 0.84 1.02 0.92 0.82 1.04 0.88þ 0.76 1.01 0.99 0.88 1.10
FMPS e Parental expectations 0.93 0.84 1.02 0.92 0.82 1.04 0.88* 0.78 1.00 0.98 0.91 1.07
FMPS e Parental criticism 0.91 0.80 1.04 0.92 0.80 1.07 0.84 0.72 1.01 0.98 0.91 1.07
CBRQ e Damaging beliefs 1.00 0.89 1.12 1.01 0.88 1.15 0.99 0.87 1.12 0.97 0.88 1.08
CBRQ e Fear avoidance 1.00 0.88 1.13 0.79* 0.65 0.97 0.91 0.80 1.04 0.99 0.89 1.10
CBRQ e Catastrophizing 0.83* 0.70 0.97 1.01 0.88 1.17 0.95 0.85 1.05 1.02þ 0.92 1.10
CBRQ e Embarrassment 0.95 0.88 1.04 0.96 0.87 1.05 0.90* 0.81 1.00 0.97 0.85 1.12
CBRQ e Avoidance/resting 0.96 0.87 1.05 0.96 0.86 1.06 0.84þ 0.70 1.01 1.04þ 0.96 1.11
CBRQ e Symptom focussing 0.99 0.90 1.09 0.99 0.89 1.10 0.96 0.85 1.07 1.00 0.92 1.01
CBRQ e All-or-nothing 0.98þ 0.89 1.01 0.98 0.88 1.10 0.96 0.86 1.07 1.02þ 0.94 1.11
Beliefs about emotions 1.00 0.97 1.04 1.00þ 0.96 1.04 1.02 0.98 1.07 0.98 0.90 1.07
Work and social adjustment scale 0.92** 0.86 0.98 0.91** 0.84 0.98 0.90** 0.83 0.97 0.98þ 0.95 1.00
HAD e Depression 0.84* 0.72 0.97 0.80* 0.66 0.97 0.87þ 0.74 1.03 0.96* 0.91 0.99
HAD e Anxiety 0.92 0.83 1.03 0.96 0.84 1.08 0.92 0.81 1.04 0.97 0.87 1.09
þp < 0.1, *p < 0.05, **p < 0.01, p < 0.001; CFQ¼ Chalder fatigue questionnaire, SF-36¼medical outcomes short form physical functioning subscale, HAD¼Hospital anxiety and
depression scale, FMPS ¼ Frost multidimensional perfectionism scale, CBRQ ¼ Cognitive and behavioural response questionnaire.
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the Oxford and the CDC criteria, and more patients were within
normal population levels of fatigue and physical functioning at 6
months follow-up compared to the pre-treatment assessment.
Utilising a combined recovery score 18.3% was totally recovered.Table 4
Four multivariate logistic regression analyses with measures of recovery at 6 month
follow up as outcome variables (points 1e4) and predictor variables assessed before
treatment.
OR 95% C.I.
1 Not meeting CDC and Oxford criteria e Follow-up
CBRQ e Catastrophising 0.87 0.73 1.04
CBRQ e All-or-nothing 1.03 0.92 1.15
Work and social adjustment scale 0.94 0.88 1.02
HAD e Depression 0.92 0.76 1.11
2 Global improvement scale e Follow-up
Months with CFS 1.00 0.99 1.00
CBRQ e Fear avoidance 0.92 0.81 1.05
Beliefs about emotions 0.95* 0.91 0.99
Work and social adjustment scale 1.01 0.94 1.08
HAD e Depression 0.79* 0.67 0.94
3 Scoring <18 on the CFQ e Follow-up
Acceptance 1.05 0.98 1.12
FMPS e Concerns about mistakes 1.02 0.95 1.10
FMPS e Doubts over actions 1.08 0.94 1.24
FMPS e Parental expectations 1.03 0.92 1.15
CBRQ e Embarrassment 1.06 0.97 1.17
CBRQ e Avoidance/resting 0.96 0.87 1.08
Work and social adjustment scale 1.09* 1.02 1.17
HAD e Depression 0.94 0.81 1.08
4 Scoring >¼65 on the SF-36 e Follow-up
Months with CFS 1.00 0.99 1.00
Age 0.93* 0.88 0.98
CBRQ e Catastrophising 0.99 0.83 1.17
CBRQ e Avoidance/resting 1.09 0.96 1.24
CBRQ e All-or-nothing 0.97 0.86 1.08
Work and social adjustment scale 0.92 0.83 1.00
HAD e Depression 1.06 0.88 1.28
p < 0.05, *p < 0.01, p < 0.001.
SF-36 ¼medical outcomes short form physical functioning subscale, CFQ ¼ Chalder
fatigue scale, HAD ¼ Hospital anxiety and depression scale, FMPS ¼ Frost multidi-
mensional perfectionism scale, CBRQ ¼ Cognitive and behavioural response
questionnaire.Similar measures of recovery have been employed in previous
studies of CBT in the context of randomised controlled trials (see
Deale et al., 2001; Knoop, Bleijenberg, et al., 2007; Knoop,
Stulemeijer, et al., 2007; White et al., 2013). However, the timing
of the ﬁnal follow-up assessment varied in each study. The follow-
up in the Knoop study occurred at discharge from treatment; the
Deale study reported recovery at 12 months after randomisation (6
months follow up) and at 5-year follow-up. Finally, the White et al.
study reported recovery rates at 12 months after randomisation.
Nevertheless, to contextualise our descriptive results we will
consider these studies comparatively. In relation to the operational
criteria for CFS about half of the patients in the present study met
the Oxford criteria at follow up. This rate is similar to previous
studies carried out in the UK (Deale et al., 2001; White et al., 2013).
More than 60% of patients no longer met the CDC criteria in this
study, again, similar rates to those found in previous studies
(Knoop, Bleijenberg, et al., 2007; Knoop, Stulemeijer, et al., 2007;
White et al., 2013). Recovery deﬁned as not meeting the CDC
criteria yielded slightly higher recovery rates compared to the
Oxford criteria.
Using a self-rated global measure of improvement 60.8% of the
patients in the present study reported feeling better ormuch better.
This percentage is very similar to the results of Quarmby et al.
(2007) in which 57% of patients in routine care reported feeling
better or much better. Overall this rate is lower than the 70% global
improvement rates in the context of a randomised controlled trial
(Deale et al., 2001). Self-rated improvement was also lower than
the 78% self-rated improvement reported in the context of a
randomised trial of therapist aided internet therapy for adolescents
with CFS (Nijhof, Bleijenberg, Uiterwaal, Kimpen, & van de Putte,
2012). This sample was obviously younger and so is not directly
comparable but it does suggest that a younger cohort may have
better chances of recovery. Although the global measure does not
pertain to symptom reduction, the high prevalence of subjectively
experienced improvement attests to the beneﬁt patients experi-
enced when receiving CBT in the present study.
Knoop, Bleijenberg, et al. (2007) and Knoop, Stulemeijer, et al.
(2007) found that 48% were within 1 SD of the normal popula-
tion mean of fatigue, which is comparable to the prevalence of
48.6% found in the present study. Although different fatigue scales
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both studies. Although Deale et al. (2001) found that 63% of the
participants were within normal range of fatigue at 6 months
(Deale et al., 2001) the larger study carried out by White et al.
(2013) found only 41% of those who received CBT were within
the normal range which suggests that this ﬁgure is more accurate
within a larger cohort.
Total Recovery was measured similarly in all previous studies.
We found a total recovery rate of 18.3%, compared to 23% (Knoop,
Bleijenberg, et al., 2007), 24% (Deale et al., 2001), and 22% (White
et al., 2013) respectively. Factors such as patient selection and the
use of manualised protocols may have affected the minor differ-
ences in outcomes between the present study and the randomised
controlled trials. Nevertheless, all in all, the recovery rates found in
these studies were comparable. Meanwhile, the study of total re-
covery remains problematic in this population, where the patients
are rarely recovered or not recovered, but rather improving on a
range of outcomes all of which are continuous.
We found differences in terms of what predictors were associ-
ated with the different recovery measures. Recovery in terms of no
longer meeting CDC and Oxford criteria were related to cata-
strophizing, depression and work and social adjustment in the
univariate analyses, but not at follow-up.
Believing that expression of emotions is unacceptable and
depression were associated with worse outcome on the global
improvement scale, in the multivariate analysis. Depression and
dysthymia have previously been related to the prognosis of CFS
patients (Cairns & Hotopf, 2005; Sharpe et al., 1992). Furthermore,
the processing, expression and acceptance of emotions particularly
distressing emotions has been found to be a predictor of
improvement in chronic fatigue patients in primary care (Godfrey,
Chalder, Ridsdale, Seed, & Ogden, 2007). It also adds weight to
the cognitive model suggested by Surawy et al. (1995) in which it is
suggested that holding the belief that showing emotions is unac-
ceptable is characteristic of people who fulﬁl criteria for CFS.
Recovery from fatigue as measured by the CFQ was signiﬁcantly
related to degree of impairment (WSAS) at baseline.
Older age was related to poorer prognosis in terms of physical
functioning. Noticeably, even though the odds ratio was low, age
was a continuous variable. Thus, such an effect may be evident in
the case of a 20 years old compared to a 60 years old CFS patient.
Older age has in previous studies been related to poorer outcome/
prognosis (Cairns & Hotopf, 2005). Somewhat surprisingly, more
avoidance/resting at baseline was positively related to recovery as
deﬁned by physical functioning, while this associationwas negative
in the univariate analysis (i.e., related to reduced odds for recovery).
The relationship with recovery may indicate a difference in
response to treatment among patients with this coping strategy at
pre-treatment. Interestingly, Cella and Chadler (2010) found that
patients characterised by avoidance and resting were less likely to
show a reduction in level of fatigue symptoms (Cella, Chalder, et al.,
2011). There may be different mechanisms at play with regard to
recovery in physical function.
Strengths and limitations
This evaluation took place in routine clinical practice. While this
adds to the study's ecological validity, the non-randomized nature
of the study cannot exclude the importance of unmeasured con-
founding variables. However, issues such as patient and therapist
selection are a recurring theme also in randomized controlled trials.
The number of participants in this study was acceptable but low
resulting in limited statistical power. Some of the borderline sig-
niﬁcant ﬁndings could possibly have reached signiﬁcance with
more participants, thus we cannot exclude false negatives in thisstudy. The number of participants meant that the multivariate
analyses were only just within the limits of the ratio of number of
participants to included variables (10 to 1). Thus, the selection of
variables for the multivariate analyses was restricted to those
which were signiﬁcant or approaching signiﬁcance in order to have
a sound number of participants/number of predictor variables ratio.
All of the variables were chosen as they are theoretically important.
There was a drop-out of 27.8% in the present study. However,
this study was based on data from a routine clinical practice. There
was no screening for eligibility for participation in a research study,
as treatment was the primary focus. We did not ﬁnd any signiﬁcant
differences between patients who completed and who did not
complete the 6-month follow-up assessment in terms of baseline
fatigue criteria. We believe that the retention rate was satisfactory,
effectively reducing the likelihood of selection bias in terms of
drop-outs from the study. Nevertheless, drop-out remains a po-
tential bias in all follow-up studies.
Conclusion
In conclusion, we found recovery rates in line with previous
studies on recovery from CFS. Different predictors were related to
recovery in terms of ofﬁcial criteria, subjective improvement,
reduced fatigue symptomatology and reduced physical impair-
ment. This suggests that a broad therapeutic focus is necessary to
improve all facets of CFS, and to facilitate total recovery. CBT has
this broad focus but the number of sessions may need to be
increased to facilitate a full recovery.
Acknowledgements
Trudie Chalder acknowledges ﬁnancial support from the
Biomedical Research Centre for Mental Health at the South London
and Maudsley NHS Foundation Trust (SLaM) and the Institute of
Psychiatry at King's College London. The views expressed are those
of the authors and not necessarily those of the NHS, the NIHR or the
Department of Health. Elisabeth Flo received a PhD scholarship
from the Western Norway Regional Health Authority. We thank
Sheila Ali for her assistance with data management. We also thank
the cognitive behavioural psychotherapists, Mary Burgess, Suzanne
Roche, Sue Wilkins, Barbara Bowman and clinical psychologists
Anna Hutchinson and Antonia Dittner.
References
Bentall, R. P., Powell, P., Nye, F. J., & Edwards, R. H. T. (2002). Predictors of response
to treatment for chronic fatigue syndrome. The British Journal of Psychiatry, 181,
248e252.
Brooks, S. K., Rimes, K. A., & Chalder, T. (2011). The role of acceptance in chronic
fatigue syndrome. Journal of Psychosomatic Research, 71, 411e415.
Butler, S., Chalder, T., Ron, M., & Wessely, S. (1991). Cognitive behaviour therapy in
chronic fatigue syndrome. Journal of Neurology, Neurosurgery & Psychiatry, 54,
153e158.
Cairns, R., & Hotopf, M. (2005). A systematic review describing the prognosis of
chronic fatigue syndrome. Occupational Medicine, 55, 20e31.
Cella, M., & Chalder, T. (2010). Measuring fatigue in clinical and community settings.
Journal of Psychosomatic Research, 69, 17e22.
Cella, M., Chalder, T., & White, P. D. (2011). Does the heterogeneity of chronic fatigue
syndrome moderate the response to cognitive behaviour therapy? An explor-
atory study. Psychotherapy and Psychosomatics, 80, 353e358.
Cella, M., Sharpe, M., & Chalder, T. (2011). Measuring disability in patients with
chronic fatigue syndrome: reliability and validity of the Work and Social
Adjustment Scale. Journal of Psychosomatic Research, 71, 124e128.
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., et al.
(1993). Development of a fatigue scale. Journal of Psychosomatic Research, 3,
147e153.
Chalder, T., Butler, S., & Wessely, S. (1996). In-patient treatment of chronic fatigue
syndrome. Behavioural and Cognitive Psychotherapy, 24, 351e365.
Chambers, D., Bagnall, A. M., Hempel, S., & Forbes, C. (2006). Interventions for the
treatment, management and rehabilitation of patients with chronic fatigue
E. Flo, T. Chalder / Behaviour Research and Therapy 63 (2014) 1e88syndrome/myalgic encephalomyelitis: an updated systematic review. Journal of
the Royal Society of Medicine, 99, 506e520.
Deale, A., Husain, K., Chalder, T., & Wessely, S. (2001). Long-term outcome of
cognitive behavior therapy versus relaxation therapy for chronic fatigue syn-
drome: a 5-year follow-up study. American Journal of Psychiatry, 158,
2038e2042.
Frost, R. O., Marten, P., Lahart, C., & Rosenblate, R. (1990). The dimensions of
perfectionism. Cognitive Therapy and Research, 14, 449e468.
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., & Komaroff, A. (1994).
The chronic fatigue syndrome: a comprehensive approach to its deﬁnition and
study. Annals of Internal Medicine, 121, 953e959.
Godfrey, E., Chalder, T., Ridsdale, L., Seed, P., & Ogden, J. (2007). Investigating the
active ingredients of cognitive behaviour therapy and counselling for patients
with chronic fatigue in primary care: developing a new process measure to
assess treatment ﬁdelity and predict outcome. British Journal of Clinical Psy-
chology, 46, 253e272.
Guy, W. (1976). Clinical global impressions, ECDEU assessment manual for psycho-
pharmacology e revised. Rockville, MD: National Institute of Mental Health.
Heins, M. J., Knoop, H., Lobbestael, J., & Bleijenberg, G. (2011). Childhood
maltreatment and the response to cognitive behavior therapy for chronic fa-
tigue syndrome. Journal of Psychosomatic Research, 71, 404e410.
Jenkinson, C., Coulter, A., & Wright, L. (1993). Short form 36 (SF36) health survey
questionnaire: normative data for adults of working age. British Medical Journal,
306, 1437e1440.
Jenkinson, C., Layte, R., Coulter, A., & Wright, L. (1996). Evidence for the sensitivity of
the SF-36 health status measure to inequalities in health: results from the
Oxford healthy lifestyles survey. Journal of Epidemiology & Community Health,
50, 377e380.
Kempke, S., Goossens, L., Luyten, P., Bekaert, P., Van Houdenhove, B., & Van
Wambeke, P. (2010). Predictors of outcome in a multi-component treatment
program for chronic fatigue syndrome. Journal of Affective Disorders, 126,
174e179.
Knoop, H., Bleijenberg, G., Gielissen, M. F. M., van der Meer, J. W. M., & White, P. D.
(2007a). Is a full recovery possible after cognitive behavioural therapy for
chronic fatigue syndrome? Psychotherapy and Psychosomatics, 76, 171e176.
Knoop, H., Stulemeijer, M., Prins, J. B., van der Meer, J. W. M., & Bleijenberg, G.
(2007). Is cognitive behaviour therapy for chronic fatigue syndrome also
effective for pain symptoms? Behaviour Research and Therapy, 45, 2034e2043.
Knudsen, A. K., Henderson, M., Harvey, S. B., & Chalder, T. (2011). Long-term sickness
absence among patients with chronic fatigue syndrome. British Journal of Psy-
chiatry, 199, 430e431.
McCracken, L. M., & Eccleston, C. (2003). Coping or acceptance: what to do about
chronic pain? Pain, 105, 197e204.
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002). The Work and Social
Adjustment Scale: a simple measure of impairment in functioning. The British
Journal of Psychiatry, 180, 461e464.
Nater, U. M., Lin, J. S., Maloney, E. M., Jones, J. F., Tian, H., Boneva, R. S., et al. (2009).
Psychiatric comorbidity in persons with chronic fatigue syndrome identiﬁed
from the Georgia population. Psychosomatic Medicine, 71, 557e565.
Nijhof, S. L., Bleijenberg, G., Uiterwaal, C. S. P. M., Kimpen, J. L. L., & van de
Putte, E. M. (2012). Effectiveness of internet-based cognitive behavioural
treatment for adolescents with chronic fatigue syndrome (FITNET): a rando-
mised controlled trial. The Lancet, 379, 1412e1418.
Prins, J. B., Bazelmans, E., Van der Werf, S. P., Van de Meer, J., & Bleijenberg, G.
(2001). Cognitive-behaviour therapy for chronic fatigue syndrome: predictorsof treatment outcome. In Paper presented at the psycho-neuro-endocrino-
immunology (PNEI): A common language for the whole human body: Pro-
ceedings of the 16th World Congress on Psychosomatic Medicine, G€oteborg,
Sweden.
Prins, J. B., Bleijenberg, G., Bazelmans, E., Elving, L. D., de Boo, T. M., Severens, J. L.,
et al. (2001). Cognitive behaviour therapy for chronic fatigue syndrome: a
multicentre randomised controlled trial. The Lancet, 357, 841e847.
Prins, J. B., Bleijenberg, G., & Rouweler, E. K. (2005). Effect of psychiatric disorders on
outcome of cognitive-behavioural therapy for chronic fatigue syndrome. The
British Journal of Psychiatry, 187, 184e185.
Quarmby, L., Rimes, K. A., Deale, A., Wessely, S., & Chalder, T. (2007). Cognitive-
behaviour therapy for chronic fatigue syndrome: comparison of outcomes
within and outside the conﬁnes of a randomised controlled trial. Behaviour
Research and Therapy, 45, 1085e1094.
Rimes, K. A., & Chalder, T. (2010). The beliefs about emotions scale: validity, reli-
ability and sensitivity to change. Journal of Psychosomatic Research, 68,
285e292.
Roberts, A. D. L., Charler, M. L., Papadopoulos, A., Wessely, S., Chalder, T., &
Cleare, A. J. (2010). Does hypocortisolism predict a poor response to cognitive
behavioural therapy in chronic fatigue syndrome? Psychological Medicine, 40,
515.
Sharpe, M. C., Archard, L. C., Banatvala, J. E., Borysiewicz, L. K., Clare, A. W., David, A.,
et al. (1991). A reportechronic fatigue syndrome: guidelines for research.
Journal of the Royal Society of Medicine, 84, 118.
Sharpe, M. C., Hawton, K., Seagroatt, V., & Pasvol, G. (1992). Follow up of patients
presenting with fatigue to an infectious diseases clinic. British Medical Journal,
305, 147e152.
Shega, J., Emanuel, L., Vargish, L., Levine, S. K., Bursch, H., Herr, K., et al. (2007). Pain
in persons with dementia: complex, common, and challenging. 8, 373e378.
Skerrett, T. N., & Moss-Morris, R. (2006). Fatigue and social impairment in multiple
sclerosis: the role of patients' cognitive and behavioral responses to their
symptoms. Journal of Psychosomatic Research, 61, 587e593.
Surawy, C., Hackmann, A., Hawton, K., & Sharpe, M. (1995). Chronic fatigue syn-
drome: a cognitive approach. Behaviour Research and Therapy, 33, 535e544.
Turnbull, N., Shaw, E. J., Baker, R., Dunsdon, S., Costin, N., Britton, G., et al. (2007).
Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diag-
nosis and management of chronic fatigue syndrome/myalgic encephalomyelitis (or
encephalopathy) in adults and children. London: Royal College of General
Practitioners.
White, P., Goldsmith, K., Johnson, A., Chalder, T., & Sharpe, M. (2013). Recovery from
chronic fatigue syndrome after treatments given in the PACE trial. Psychological
Medicine, 43, 2227e2235.
White, P., Sharpe, M., Chalder, T., DeCesare, J., & Walwyn, R. (2007). Protocol for the
PACE trial: a randomised controlled trial of adaptive pacing, cognitive behaviour
therapy, and graded exercise as supplements to standardised specialist medical
care versus standardised specialist medical care alone for patients with the
chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy. BMC
Neurology, 7, 6.
White, P. D., Goldsmith, K. A., Johnson, A. L., Potts, L., Walwyn, R., DeCesare, J. C.,
et al. (2011). Comparison of adaptive pacing therapy, cognitive behaviour
therapy, graded exercise therapy, and specialist medical care for chronic fatigue
syndrome (PACE): a randomised trial. The Lancet, 823e836.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta
Psychiatrica Scandinavica, 67, 361e370.
